Trial intelligence / Profile preview

Melatonin for children with ADHD and chronic sleep onset insomnia

NL-OMON25413Active, not recruiting

Start
Nov 2001
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in Sleep onset insomnia and attention deficit hyperactivity disorder (ADHD) comparing Melatonin with Placebo (2 arms). Primary endpoints: Sleep onset, sleep latency, and total sleep duration and Salivary dim light melatonin onset. Started Nov 2001; status: active, not recruiting.

02

Drugs

melatonin
03

Conditions

Sleep onset insomniaattention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NL-OMON25413.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON25413.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call